Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Christian Fesl"'
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Purpose:Accurate response assessment during neoadjuvant systemic treatment (NST) poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response based on cell-free circulating tumor DNA (ctDNA) may be beneficial to guide trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ed243da79c1c37626cfbc7ae763edc
https://doi.org/10.1158/1078-0432.c.6532496
https://doi.org/10.1158/1078-0432.c.6532496
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Supplementary Figure from Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11bc36db6ecc63d35820191d0eb5f100
https://doi.org/10.1158/1078-0432.22487330
https://doi.org/10.1158/1078-0432.22487330
Autor:
Michael Gnant, J. Wayne Cowens, Shuzhen Liu, Sean Ferree, Carl Schaper, Christian Fesl, Harald Trapl, Michael Knauer, Michael Hubalek, Thomas Bauernhofer, Peter Dubsky, Brigitte Mlineritsch, Christian F. Singer, Elisabeth Müller-Holzner, Christine Gruber-Rossipal, Peter Regitnig, Otto Dietze, Zsuzsanna Bago-Horvath, Raimund Jakesz, Herbert Stöger, Richard Greil, Margaretha Rudas, Torsten O. Nielsen, Martin Filipits
PDF file - 34K, Supplementary Table S1. ROR cutoff values for risk groups defined by nodal status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20887cf3aa596363e0682b249ea375d2
https://doi.org/10.1158/1078-0432.22449326
https://doi.org/10.1158/1078-0432.22449326
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Supplementary Table from Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e466503ce14d784db53d6e97b43b5c0
https://doi.org/10.1158/1078-0432.22487306
https://doi.org/10.1158/1078-0432.22487306
Autor:
Eileen Shinn, David Zahrieh, Angela DeMichele, Nick Zdenkowski, Julie Lemieux, Jun Mao, Vesna Bjelic-Radisic, Michelle Naughton, Georg Pfeiler, Karen Gelmon, Ingrid Mayer, Daniel Egle, Gabriele Zoppoli, Tiffany Traina, Miguel Martin Jiménez, Silvia Antolin Novoa, Tufia Haddad, Arlene Chan, Alistair Edward Ring, Antonio Wolff, Jose JuanPonce Lorenzo, Dhanusha Sabanathan, Hal Burstein, Zbigniew Ireneusz Nowecki, Gunda Pristauz-Telsnigg, Adam Brufsky, Meritxell Bellet-Ezquerra, Theodoros Foukakis, Yelena Novik, Gabor Rubovszky, Karoline Muehlbacher, Otto Metzger, Theodora Goulioti, Ernest Law, Ann Partridge, Lisa Carey, Alex Zoroufy, Dominik Hlauschek, Christian Fesl, Erica Mayer, Michael Gnant
Publikováno v:
Cancer Research. 82:P4-12
Background: As the development and use of oral anticancer agents increases, it is critical to understand patient adherence to both standard and investigational agents. The open label, phase 3 multicenter PALLAS trial investigates whether adding 2 yea
Autor:
Michael, Gnant, Amylou C, Dueck, Sophie, Frantal, Miguel, Martin, Hal J, Burstein, Richard, Greil, Peter, Fox, Antonio C, Wolff, Arlene, Chan, Eric P, Winer, Georg, Pfeiler, Kathy D, Miller, Marco, Colleoni, Jennifer M, Suga, Gabor, Rubovsky, Judith M, Bliss, Ingrid A, Mayer, Christian F, Singer, Zbigniew, Nowecki, Olwen, Hahn, Jacqui, Thomson, Norman, Wolmark, Kepa, Amillano, Hope S, Rugo, Guenther G, Steger, Blanca, Hernando Fernández de Aránguiz, Tufia C, Haddad, Antonia, Perelló, Meritxell, Bellet, Hannes, Fohler, Otto, Metzger Filho, Anita, Jallitsch-Halper, Kadine, Solomon, Céline, Schurmans, Kathy P, Theall, Dongrui R, Lu, Kathleen, Tenner, Christian, Fesl, Angela, DeMichele, Erica L, Mayer
Publikováno v:
Journal of Clinical Oncology. 40:282-293
PURPOSE Palbociclib is a cyclin-dependent kinase 4 and 6 inhibitor approved for advanced breast cancer. In the adjuvant setting, the potential value of adding palbociclib to endocrine therapy for hormone receptor–positive breast cancer has not been
Autor:
Zsuzsanna Bago-Horvath, Anders Ståhlberg, Christian F. Singer, Michael Gnant, Georg Pfeiler, Marija Balic, Christian Fesl, Edgar Petru, Nadia Dandachi, Sophie Frantal, Gabriel Rinnerthaler, Daniel Egle, Martin Filipits, Ellen Heitzer, Ricarda Graf, Simon Peter Gampenrieder, Viktor Wette, Sabrina Weber, Rupert Bartsch, Margaretha Rudas, Peter Dubsky, Angelika Pichler, Qing Zhou
Publikováno v:
Clinical Cancer Research. 28:697-707
Purpose: Accurate response assessment during neoadjuvant systemic treatment (NST) poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response based on cell-free circulating tumor DNA (ctDNA) may be beneficial to guide tre
Autor:
Michael Gnant, Sophie Frantal, Georg Pfeiler, Guenther G. Steger, Daniel Egle, Richard Greil, Florian Fitzal, Viktor Wette, Marija Balic, Ferdinand Haslbauer, Elisabeth Melbinger-Zeinitzer, Vesna Bjelic-Radisic, Silvia Artner-Matuschek, Franz Kainberger, Magdalena Ritter, Gabriel Rinnerthaler, Paul Sevelda, Jonas Bergh, Stephanie Kacerovsky-Strobl, Christoph Suppan, Christine Brunner, Christine Deutschmann, Simon P. Gampenrieder, Hannes Fohler, Raimund Jakesz, Christian Fesl, Christian Singer
Publikováno v:
NEJM Evidence. 1
Autor:
Ana-Alicia Beltran-Bless, Mark J. Clemons, Christian Fesl, Richard Greil, Gregory R. Pond, Marija Balic, Lisa Vandermeer, Vesna Bjelic-Radisic, Christian F. Singer, Guenther G. Steger, Ruth Helfgott, Daniel Egle, Lidija Sölkner, Simon P. Gampenrieder, Stephanie Kacerovsky-Strobl, Christoph Suppan, Magdalena Ritter, Gabriel Rinnerthaler, Georg Pfeiler, Hannes Fohler, Dominik Hlauschek, John Hilton, Michael Gnant
Publikováno v:
European journal of cancer (Oxford, England : 1990). 180
The widespread adoption of adjuvant bisphosphonate therapy for postmenopausal early breast cancer (EBC) patients was based on results of the Early Breast Cancer Trialist Group (EBCTCG) meta-analysis. Despite multiple regimens evaluated, there was no
Autor:
Michael, Gnant, Florian, Fitzal, Gabriel, Rinnerthaler, Guenther G, Steger, Sigrun, Greil-Ressler, Marija, Balic, Dietmar, Heck, Raimund, Jakesz, Josef, Thaler, Daniel, Egle, Diether, Manfreda, Vesna, Bjelic-Radisic, Ursula, Wieder, Christian F, Singer, Elisabeth, Melbinger-Zeinitzer, Ferdinand, Haslbauer, Paul, Sevelda, Harald, Trapl, Viktor, Wette, Kerstin, Wimmer, Simon P, Gampenrieder, Rupert, Bartsch, Stephanie, Kacerovsky-Strobl, Christoph, Suppan, Christine, Brunner, Christine, Deutschmann, Lidija, Soelkner, Christian, Fesl, Richard, Greil, B, Tausch
Publikováno v:
New England Journal of Medicine. 385:395-405
For postmenopausal women with hormone-receptor-positive breast cancer, the most effective duration for adjuvant therapy with an aromatase inhibitor remains unclear.In this prospective, phase 3 trial, we randomly assigned postmenopausal women with hor